Search research articles
Contact Us
Filters
Showing results (151-160 of 290) with videos related to
Page
of 29
Sort By:
American Heart Journal
|
June 9, 2021
Regional variation of effects of new antidiabetic medications in cardiovascular outcome trials
Gad Cotter, Beth A Davison, Christopher Edwards, et al.
JACC. Heart Failure
|
April 4, 2016
Use of High-Sensitivity Troponin T to Identify Patients With Acute Heart Failure at Lower Risk for Adverse Outcomes: An Exploratory Analysis From the RELAX-AHF Trial
Peter S Pang, John R Teerlink, Adriaan A Voors, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
February 3, 2017
Serelaxin in acute heart failure patients with and without atrial fibrillation: a secondary analysis of the RELAX-AHF trial
Gerasimos Filippatos, Dimitrios Farmakis, Marco Metra, et al.
American Heart Journal
|
April 8, 2003
Prior peripheral arterial disease and cerebrovascular disease are independent predictors of adverse outcome in patients with acute coronary syndromes: are we doing enough? Results from the Orbofiban in Patients with Unstable Coronary Syndromes-Thrombolysis In Myocardial Infarction (OPUS-TIMI) 16 study
Gad Cotter, Christopher P Cannon, Carolyn H McCabe, et al.
European Journal of Heart Failure
|
June 1, 2017
Benefit of cardiopoietic mesenchymal stem cell therapy on left ventricular remodelling: results from the Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-1) study
John R Teerlink, Marco Metra, Gerasimos S Filippatos, et al.
Journal of the American College of Cardiology
|
May 7, 2011
Effects of the adenosine A1 receptor antagonist rolofylline on renal function in patients with acute heart failure and renal dysfunction: results from PROTECT (Placebo-Controlled Randomized Study of the Selective Adenosine A1 Receptor Antagonist Rolofylline for Patients Hospitalized with Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function)
Adriaan A Voors, Howard C Dittrich, Barry M Massie, et al.
International Journal of Cardiology
|
September 20, 2021
Early intravenous nitroglycerin use in prehospital setting and in the emergency department to treat patients with acute heart failure: Insights from the EAHFE Spanish registry
Òscar Miró, Pere Llorens, Yonathan Freund, et al.
JACC. Heart Failure
|
May 9, 2015
Worsening Heart Failure Following Admission for Acute Heart Failure: A Pooled Analysis of the PROTECT and RELAX-AHF Studies
Beth A Davison, Marco Metra, Gad Cotter, et al.
International Journal of Molecular Sciences
|
July 13, 2017
Plasma Neutrophil Gelatinase-Associated Lipocalin and Predicting Clinically Relevant Worsening Renal Function in Acute Heart Failure
Kevin Damman, Mattia A E Valente, Dirk J van Veldhuisen, et al.
European Journal of Heart Failure
|
September 6, 2024
Impact of age on clinical outcomes and response to serelaxin in patients with acute heart failure: An analysis from the RELAX-AHF-2 trial
Riccardo M Inciardi, Laura Staal, Beth Davison, et al.
Page
of 29
Search research articles
Search
Showing results (151-160 of 290) with videos related to
Sort By:
Page
of 29
American Heart Journal
|
June 9, 2021
Regional variation of effects of new antidiabetic medications in cardiovascular outcome trials
Gad Cotter, Beth A Davison, Christopher Edwards, et al.
JACC. Heart Failure
|
April 4, 2016
Use of High-Sensitivity Troponin T to Identify Patients With Acute Heart Failure at Lower Risk for Adverse Outcomes: An Exploratory Analysis From the RELAX-AHF Trial
Peter S Pang, John R Teerlink, Adriaan A Voors, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
February 3, 2017
Serelaxin in acute heart failure patients with and without atrial fibrillation: a secondary analysis of the RELAX-AHF trial
Gerasimos Filippatos, Dimitrios Farmakis, Marco Metra, et al.
American Heart Journal
|
April 8, 2003
Prior peripheral arterial disease and cerebrovascular disease are independent predictors of adverse outcome in patients with acute coronary syndromes: are we doing enough? Results from the Orbofiban in Patients with Unstable Coronary Syndromes-Thrombolysis In Myocardial Infarction (OPUS-TIMI) 16 study
Gad Cotter, Christopher P Cannon, Carolyn H McCabe, et al.
European Journal of Heart Failure
|
June 1, 2017
Benefit of cardiopoietic mesenchymal stem cell therapy on left ventricular remodelling: results from the Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-1) study
John R Teerlink, Marco Metra, Gerasimos S Filippatos, et al.
Journal of the American College of Cardiology
|
May 7, 2011
Effects of the adenosine A1 receptor antagonist rolofylline on renal function in patients with acute heart failure and renal dysfunction: results from PROTECT (Placebo-Controlled Randomized Study of the Selective Adenosine A1 Receptor Antagonist Rolofylline for Patients Hospitalized with Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function)
Adriaan A Voors, Howard C Dittrich, Barry M Massie, et al.
International Journal of Cardiology
|
September 20, 2021
Early intravenous nitroglycerin use in prehospital setting and in the emergency department to treat patients with acute heart failure: Insights from the EAHFE Spanish registry
Òscar Miró, Pere Llorens, Yonathan Freund, et al.
JACC. Heart Failure
|
May 9, 2015
Worsening Heart Failure Following Admission for Acute Heart Failure: A Pooled Analysis of the PROTECT and RELAX-AHF Studies
Beth A Davison, Marco Metra, Gad Cotter, et al.
International Journal of Molecular Sciences
|
July 13, 2017
Plasma Neutrophil Gelatinase-Associated Lipocalin and Predicting Clinically Relevant Worsening Renal Function in Acute Heart Failure
Kevin Damman, Mattia A E Valente, Dirk J van Veldhuisen, et al.
European Journal of Heart Failure
|
September 6, 2024
Impact of age on clinical outcomes and response to serelaxin in patients with acute heart failure: An analysis from the RELAX-AHF-2 trial
Riccardo M Inciardi, Laura Staal, Beth Davison, et al.
Page
of 29